Patent intelligence · US
US 9554999
Lyophilization of synthetic liposomal pulmonary surfactant
Lyophilization of synthetic liposomal pulmonary surfactant
Patent details — US 9554999
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 31, 2017
- Expiration
- Jan 26, 2037
- Applicant
- Windtree Therapeutics, Inc.
- Claims
- 16
- CPC classes
- A61K, A61K31/20, A61K31/661, A61K31/683
Quick answer
US 9554999 (Lyophilization of synthetic liposomal pulmonary surfactant) is held by Windtree Therapeutics, Inc.. Status: granted. Granted Jan 31, 2017. Expires Jan 26, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Windtree Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K31/20, A61K31/661, A61K31/683, A61K31/685, A61K38/395
More from Windtree Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12343350
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted -
US 11583540
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted -
US 11197869
Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)
granted
Frequently asked questions
What is US patent 9554999?
US 9554999 (Lyophilization of synthetic liposomal pulmonary surfactant) is held by Windtree Therapeutics, Inc.. Status: granted. Granted Jan 31, 2017. Expires Jan 26, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9554999?
Windtree Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 9554999 expire?
Our index shows an expiration date of Jan 26, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.